Netflix (NFLX) beat EPS estimates by a penny on July 16. Shares fell as much as 9% after hours anyway, landing below their 52-week low. The beat wasn't the story. The guidance was.
What Netflix actually reported
The numbers were fine. Q2 revenue hit $12.56B, up 13% year over year, just shy of the $12.59B consensus. EPS came in at $0.80 against a $0.79 estimate.
Net income reached $3.4B. Netflix also narrowed its full-year revenue guidance to $51B to $51.4B, tightening the range instead of widening it.
The company bought back $4.7B in stock during the quarter, its largest single-quarter repurchase ever. None of that moved the needle. Q3 guidance did.
Why the stock fell anyway
A beat that doesn't guide up isn't a beat the market wants. Netflix guided Q3 revenue to $12.86B, below Wall Street's roughly $13B target. Q3 EPS guidance of $0.82 also missed the $0.84 estimate.
That gap looks small on paper. It read as deceleration on the call. Analysts pushed hard on engagement, and Netflix called viewing hours "healthy," pointing to more than 97 billion hours watched in the first half of the year. Co-CEO Greg Peters didn't dodge the pushback. "Not all hours are created equal," he told analysts, arguing that live events drive revenue without racking up raw viewing time.
Shares were already down 20% to 21% year to date heading into the print. Tonight didn't reverse that. It extended it.
What Netflix's Health Score reveals
Here's the number that didn't move tonight: Netflix's Health Score sits at 7.8 out of 10, the highest of any Entertainment stock in the Stoxcraft universe, ahead of Disney (DIS) and Fox (FOX). Nothing in the guidance touched that.
The engine behind it is cash flow, not hype. Return on equity runs 41.3%, and Netflix earns 16.3 times what it needs to cover its interest payments. That's not a company sweating its cash flow.
The one gap keeping the score from perfect: a current ratio of 1.19, adequate but unremarkable. It's the detail that stops an elite Health Score from becoming a flawless one.
How Netflix's performance compares
The Performance Score tells the opposite story. At 4.1 out of 10, Netflix ranks #18 of 28 Entertainment stocks, below the industry median. A great business can still have a bad stock chart, and this is what that looks like.
Shares are down 40.5% over the past year and 31% over the past three months. That decline predates tonight's print by months. Zoom out to three years and the return is still positive at 65.2%, but recent momentum has erased most of that edge against peers.
Shares dropped as much as 9% Thursday to their lowest levels in more than a year, extending a slide the Performance Score had already flagged weeks before the call.
What the trend and entry signals are showing
The technical setup is dipping, not crashing. RSI sits at 42, under the neutral 50 line but nowhere near oversold territory.
The entry signal reads Hold. That's neutral, not bearish. The setup isn't attractive enough to chase, but it isn't flashing a warning either.
Beta of 1.52 means Netflix swings about 50% harder than the broader market in both directions. That's why a mostly in-line quarter turned into a 9% after-hours drop instead of a shrug.
The pattern to watch in NFLX right now
Strong fundamentals, weak momentum, neutral entry signal: that's a Value Trap Warning, and it's the setup where good businesses get punished for bad timing.
The Health Score hasn't budged in months while the Performance Score keeps sliding. Tonight's guidance gave the market one more reason to wait instead of buy. Good numbers don't fix a stock the market has already decided to distrust.
What Netflix needs to prove next quarter
Forget another earnings beat. The real test is whether Q3 revenue actually clears $12.86B, and whether the engagement debate cools off before it becomes the whole narrative.
Netflix's own filing leaned on the word "engagement" repeatedly, which tells you exactly what the company thinks investors are watching. Until that resolves, the Health Score and Performance Score will keep telling two different stories about the same stock.
Stoxcraft scores are quantitative indicators based on Financial Modeling Prep data, not investment advice. This article is for informational purposes only and does not constitute financial, investment, or trading advice. Always conduct your own research before making investment decisions.
